498 related articles for article (PubMed ID: 30706168)
1. How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Hoch E; Niemann D; von Keller R; Schneider M; Friemel CM; Preuss UW; Hasan A; Pogarell O
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):87-105. PubMed ID: 30706168
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
3. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Spanagel R; Bilbao A
Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
5. Cannabis-based products for pediatric epilepsy: An updated systematic review.
Elliott J; DeJean D; Clifford T; Coyle D; Potter BK; Skidmore B; Alexander C; Repetski AE; Shukla V; McCoy B; Wells GA
Seizure; 2020 Feb; 75():18-22. PubMed ID: 31865133
[TBL] [Abstract][Full Text] [Related]
6. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
8. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
Deiana S
Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
[TBL] [Abstract][Full Text] [Related]
9. Cannabis in Parkinson's Disease: The Patients' View.
Yenilmez F; Fründt O; Hidding U; Buhmann C
J Parkinsons Dis; 2021; 11(1):309-321. PubMed ID: 33216043
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of cannabidiol trials in neurodevelopmental disorders.
Parrella NF; Hill AT; Enticott PG; Barhoun P; Bower IS; Ford TC
Pharmacol Biochem Behav; 2023 Sep; 230():173607. PubMed ID: 37543051
[TBL] [Abstract][Full Text] [Related]
11. Practical considerations in medical cannabis administration and dosing.
MacCallum CA; Russo EB
Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of medicinal cannabis: results of the CaPRis study].
Hoch E; Friemel C; Schneider M; Pogarell O; Hasan A; Preuss UW;
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):825-829. PubMed ID: 31214723
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications.
Wilkinson ST; Radhakrishnan R; D'Souza DC
J Clin Psychiatry; 2016 Aug; 77(8):1050-64. PubMed ID: 27561138
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
[TBL] [Abstract][Full Text] [Related]
15. Cannabis based medicines and cannabis dependence: A critical review of issues and evidence.
Schlag AK; Hindocha C; Zafar R; Nutt DJ; Curran HV
J Psychopharmacol; 2021 Jul; 35(7):773-785. PubMed ID: 33593117
[TBL] [Abstract][Full Text] [Related]
16. Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors.
Brunetti P; Pichini S; Pacifici R; Busardò FP; Del Rio A
Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32429074
[TBL] [Abstract][Full Text] [Related]
17. Promoting cannabis products to pharmaceutical drugs.
Koltai H; Poulin P; Namdar D
Eur J Pharm Sci; 2019 Apr; 132():118-120. PubMed ID: 30851400
[TBL] [Abstract][Full Text] [Related]
18. Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users.
Turna J; Simpson W; Patterson B; Lucas P; Van Ameringen M
J Psychiatr Res; 2019 Apr; 111():134-139. PubMed ID: 30738930
[TBL] [Abstract][Full Text] [Related]
19. Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies.
Crichton M; Dissanayaka T; Marx W; Gamage E; Travica N; Bowers A; Isenring E; Yates P; Marshall S
Maturitas; 2024 Jun; 184():107941. PubMed ID: 38430618
[TBL] [Abstract][Full Text] [Related]
20. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
